William Asch, MD/PhD, BA
Associate Professor of Medicine (Nephrology)Cards
About
Titles
Associate Professor of Medicine (Nephrology)
Program Director, Transplant Nephrology Fellowship Program, Internal Medicine; Director of Pre-Transplant Operations, Internal Medicine
Biography
My clinical, educational, administrative, and scholarly efforts are centered on solid organ transplantation. While the majority of this effort focuses on kidney transplantation, I provide subspecialty consultative services to the liver, heart, and bone marrow transplant programs. As the Transplant Nephrology Fellowship Program Director, I established the required policies, procedures, and documents required to establish this program. The program is accredited through the American Society of Transplantation. Yale is one of 62 accredited programs in the US. Approved by the Yale Office of Graduate Medical Education, The Yale Transplant Nephrology Fellowship Program has graduated 6 fellows. My scholarly activities range from an Investigator-Initiated Research project investigating the neurocognitive impairments associated with tacrolimus, the cornerstone immunosuppressant used to prevent rejection in solid organ transplant recipients. The favorable proof of concept results (confirming that clinicians can perform a high level cognitive assessment in the clinic setting using the NIH-Tool Box Cognitive Battery) and pilot data have led to this project expanding into 16 site multicenter trial (The ABCs Trial). In addition, I am the Principal Investigator for pharmaceutical sponsored clinical trials on immune tolerance, BK viremia, and delayed progression of diabetic kidney disease.
Appointments
Nephrology
Associate Professor on TermPrimary
Other Departments & Organizations
- Internal Medicine
- Kidney Transplant Program
- Liver & Pancreas Transplant Program
- Nephrology
- Yale Medicine
- Yale Ventures
Education & Training
- Fellow
- Yale University School of Medicine (2008)
- Resident
- Yale-New Haven Hospital (2004)
- MD/PhD
- SUNY at Stonybrook (2001)
- BA
- Brandeis University (1993)
Research
Publications
2024
Is PET the Best Screening Tool for Cardiac Assessment Prior to Renal Transplant?
Sinusas A, Asch W. Is PET the Best Screening Tool for Cardiac Assessment Prior to Renal Transplant? Circulation Cardiovascular Imaging 2024, 17: e016408. PMID: 38227693, DOI: 10.1161/circimaging.123.016408.Peer-Reviewed Original Research
2023
Progressive Multifocal Leukoencephalopathy (PML): A Dreaded Complication of Immunosuppression
Garcilazo N, Virmani S, Asch W. Progressive Multifocal Leukoencephalopathy (PML): A Dreaded Complication of Immunosuppression. Journal Of The American Society Of Nephrology 2023, 34: 610-610. DOI: 10.1681/asn.20233411s1610a.Peer-Reviewed Original Research
2022
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity
Sun Z, Zhang Z, Banu K, Al Azzi Y, Reghuvaran A, Fredericks S, Planoutene M, Hartzell S, Kim Y, Pell J, Tietjen G, Asch W, Kulkarni S, Formica R, Rana M, Maltzman JS, Zhang W, Akalin E, Heeger PS, Cravedi P, Menon MC. Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity. Journal Of The American Society Of Nephrology 2022, 33: 2108-2122. PMID: 36041788, PMCID: PMC9678030, DOI: 10.1681/asn.2022010125.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsImmune activation pathwaysImmunosuppressant useKTR cohortAcute illnessBlood transcriptomeAcute casesT cellsCOVID-19Most kidney transplant recipientsPost-acute COVID-19Adaptive immune system activationManagement of immunosuppressionReinstitution of immunosuppressionAcute COVID-19Serum inflammatory cytokinesCOVID-19 severity scoreCOVID-19 infectionImmune system activationUpregulation of neutrophilActivation pathwayTransplant recipientsChart reviewImmune signaturesLymphocyte countIs Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? COMMENTARY
Asch WS. Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? COMMENTARY. Kidney360 2022, 3: 999-1002. PMID: 35849645, PMCID: PMC9255872, DOI: 10.34067/kid.0005042021.Peer-Reviewed Original Research
2021
Evaluating the Impact and Rationale of Race-Specific Estimations of Kidney Function: Estimations from U.S. NHANES, 2015-2018
Tsai JW, Cerdeña JP, Goedel WC, Asch WS, Grubbs V, Mendu ML, Kaufman JS. Evaluating the Impact and Rationale of Race-Specific Estimations of Kidney Function: Estimations from U.S. NHANES, 2015-2018. EClinicalMedicine 2021, 42: 101197. PMID: 34849475, PMCID: PMC8608882, DOI: 10.1016/j.eclinm.2021.101197.Peer-Reviewed Original ResearchNephrologist referralPopulation-representative cross-sectional dataStage 3 chronic kidney diseaseUnited States National HealthRace adjustmentChronic kidney diseaseModification of DietRenal Disease equationGlomerular filtration rateKidney disease managementNutrition Examination SurveyManagement of kidneyTransplantation listingTransplant evaluationSerum creatinineBlack patientsEGFR valuesKidney functionKidney diseaseExamination SurveyKidney disease diagnosisFiltration rateNational HealthClinical careDiagnostic thresholdAttenuated COVID-19 Severity in the MDR-101 MLK MERCURY Tolerance Study
Kant S, Akkina S, Asch W, Brennan D. Attenuated COVID-19 Severity in the MDR-101 MLK MERCURY Tolerance Study. Journal Of The American Society Of Nephrology 2021, 32: b12-b12. DOI: 10.1681/asn.20213210s1b12c.Peer-Reviewed Original ResearchGenetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States
Azar MM, Cohen E, Ma L, Cissé OH, Gan G, Deng Y, Belfield K, Asch W, Grant M, Gleeson S, Koff A, Gaston DC, Topal J, Curran S, Kulkarni S, Kovacs JA, Malinis M. Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States. Clinical Infectious Diseases 2021, 74: 639-647. PMID: 34017984, PMCID: PMC9012955, DOI: 10.1093/cid/ciab474.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsCases of PCPPneumocystis pneumoniaClinic visitsRisk factorsClinic exposureLow absolute lymphocyte countRisk of PCPAbsolute lymphocyte countFrequent clinic visitsPneumocystis jirovecii pneumoniaStrong risk factorNon-white raceCase-control analysisBelatacept groupMonthly infusionsTransplant recipientsBaseline characteristicsJirovecii pneumoniaLymphocyte countMultilocus sequence typingInterhuman transmissionRespiratory specimensUnivariate analysisEpidemiologic dataImpact of Low-Dose Fluconazole on Tacrolimus Dosing in Renal Transplant
Johnston JP, Cohen EA, Casal GH, Asch WS, Reardon DP. Impact of Low-Dose Fluconazole on Tacrolimus Dosing in Renal Transplant. Journal Of Pharmacy Practice 2021, 35: 701-706. PMID: 33759619, DOI: 10.1177/08971900211000702.Peer-Reviewed Original ResearchConceptsLow-dose fluconazoleRenal transplant patientsAdverse drug reactionsTAC levelsTransplant patientsGraft rejectionDrug reactionsTherapeutic levelsSingle-center retrospective chart reviewPost-operative day 10Azole antifungal therapySubtherapeutic tacrolimus levelsTAC dose adjustmentRenal transplant recipientsTotal daily doseRetrospective chart reviewTacrolimus dosingTacrolimus levelsRenal transplantTransplant recipientsChart reviewSecondary outcomesDaily doseDose adjustmentPrimary outcomeIs prioritization of kidney allografts to combined liver-kidney recipients appropriate? Discussion of the Pros and Cons.
Asch WS. Is prioritization of kidney allografts to combined liver-kidney recipients appropriate? Discussion of the Pros and Cons. Kidney360, In Press, 2021Peer-Reviewed Original Research In Press
2020
Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability—Does One Exist?
Virmani S, Gleeson SE, Girone GF, Malhotra D, Cohen EA, Klarman SE, Asch WS. Identifying a Kidney Transplant Recipient COVID Phenotype to Aid Test Utilization in the Setting of Limited Testing Availability—Does One Exist? Transplantation Proceedings 2020, 52: 2584-2591. PMID: 32711848, PMCID: PMC7305913, DOI: 10.1016/j.transproceed.2020.05.033.Peer-Reviewed Original ResearchConceptsKidney transplant recipientsSARS-CoV-2BK viremiaLimited testing availabilityTesting availabilitySevere acute respiratory syndrome 2 virusImmunosuppressed kidney transplant recipientsOutpatient testing centerPolyoma BK viremiaCOVID-19 infectionPositive predictive valueTransplant recipientsImmunocompetent patientsSymptomatic patientsImmunosuppressed patientsTransplant centersHigh morbidityEmergency departmentInpatient treatmentGeneral populationHigh incidencePatientsCenter deliveriesPredictive valueTest utilization
Clinical Trials
Current Trials
Evaluating Biomarker-Guided Medication Changes in Kidney Transplant Patients
HIC ID2000033724RoleSub InvestigatorPrimary Completion Date12/31/2023Recruiting ParticipantsAge18 years - 70 yearsMulticenter, Open Label, Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)
HIC ID2000021894RolePrincipal InvestigatorPrimary Completion Date06/30/2022Recruiting ParticipantsGenderBoth
Academic Achievements & Community Involvement
Teaching & Mentoring
Mentoring
Arun Chutani
Postdoc2023 - 2024Arundati Rao, MBBS
Faculty2022 - PresentPriyanka Jethwani MBBS
Postdoc2021 - 2022Zubair Saeed Zafar MD
Postdoc2020 - 2021
Clinical Care
Overview
William Asch, MD, PhD, is a nephrologist who focuses on kidney transplantation and says he enjoys the challenge of a complicated case.
“I really like the puzzle of trying to figure out what is going on with a patient who has complex problems and helping them,” Dr. Asch says. “There is nothing more gratifying than taking someone who has been on dialysis for six weeks, six years, or 13 years and giving them a new kidney and seeing their life transform in the best of ways.”
Growing up, Dr. Asch says he pretty much knew he wanted to become a doctor. “I remember having profound respect for our family physician and seeing a microscope in his office and being really interested in that,” he says. “I was very interested in physics in high school but then settled into biological sciences with a focus on physiology in college.”
In addition to his medical degree, Dr. Asch has a doctorate degree in molecular biology, which ended up being a good fit at Yale, given the medical school’s strong history in laboratory-based nephrology research.
“For me, kidney transplantation is a great pairing of my interests in lab work, physiology, and physics,” he says. “And what I love is that there is an overlap with so many different fields that make my job so fascinating. Transplant nephrologists aren’t in a vacuum. We work closely with colleagues from infectious diseases, cardiology, and many other specialties.”
An active researcher, Dr. Asch is exploring the underappreciated neurocognitive impairment associated with tacrolimus, an immunosuppressant medication. “It’s challenging to study, but we have an eye on the possibility that some of our newest drugs might not have that same negative impact on cognition,” Dr. Asch says.
Clinical Specialties
Fact Sheets
Kidney Transplant
Learn More on Yale MedicinePediatric Kidney Transplant
Learn More on Yale MedicineLiving Donor Organ Transplantation
Learn More on Yale MedicineAcute Kidney Injury (AKI)
Learn More on Yale Medicine
Board Certifications
Nephrology
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2016
- Original Certification Date
- 2006
Internal Medicine
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2015
- Original Certification Date
- 2004